Lankenau Institute For Medical Research
- Assets
- $20.4m
- Revenue
- $11.7m
- Investments
- $0.0
- Employees
- 110
- Location
- Wynnewood, PA
- Founding
- 01/1982
- Data as of
- 06/2022
- EIN
- 23-2175659
Organization Overview
Lankenau Institute For Medical Research is located in Wynnewood, PA. The organization was established in 1982. According to its NTEE Classification (H99) the organization is classified as: Medical Research N.E.C., under the broad grouping of Medical Research and related organizations. As of 06/2022, Lankenau Institute For Medical Research employed 110 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Lankenau Institute For Medical Research is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2022, Lankenau Institute For Medical Research generated $11.7m in total revenue. This represents relatively stable growth, over the past 7 years the organization has increased revenue by an average of 4.0% each year. All expenses for the organization totaled $18.3m during the year ending 06/2022. While expenses have increased by 2.8% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990T
Mission & Program ActivityExcerpts From the 990T Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
ADVANCE HUMAN HEALTH/WELL BEING, IMPROVE DETECTION/TREATMENT OF DISEASE, TRANSFER NEW TECHNOLOGY TO THE CLINIC & TRAIN THE NEXT GENERATION OF SCIENTISTS & PHYSICIANS.
Describe the Organization's Program Activity:
BASIC RESEARCH LIMR BASIC RESEARCH FOCUSES ON THE ADVANCEMENT OF KNOWLEDGE FOR VARIOUS DISEASES AND CONDITIONS. IN CONJUNCTION WITH LIMR'S CORE RESEARCH PROGRAMS IN CANCER AND CARDIOVASCULAR DISEASE, LIMR INVESTIGATORS ALSO STUDY ARTHRITIS, DIABETES, LUPUS, INFECTIOUS DISEASE, NEUROLOGICAL DISORDERS, GASTROINTESTINAL DISEASE, REGENERATIVE MEDICINE AND POPULATION HEALTH, ALL WITH THE GOAL OF IMPROVING HEALTH AND WELL-BEING.
BASIC RESEARCH LIMR BASIC RESEARCH FOCUSES ON THE ADVANCEMENT OF KNOWLEDGE FOR VARIOUS DISEASES AND CONDITIONS. IN CONJUNCTION WITH LIMR'S CORE RESEARCH PROGRAMS IN CANCER AND CARDIOVASCULAR DISEASE, LIMR INVESTIGATORS ALSO STUDY ARTHRITIS, DIABETES, LUPUS, INFECTIOUS DISEASE, NEUROLOGICAL DISORDERS, GASTROINTESTINAL DISEASE, REGENERATIVE MEDICINE AND POPULATION HEALTH, ALL WITH THE GOAL OF IMPROVING HEALTH AND WELL-BEING.
CLINICAL RESEARCH LIMR CLINICAL RESEARCH IS CONDUCTED PRIMARILY IN ONCOLOGY AND CARDIOLOGY BUT ALSO INCLUDES OTHER DISEASES AND DISORDERS. THIS MEANS PATIENTS AND PARTICIPANTS HAVE ACCESS TO STATE-OF-THE-ART CLINICAL TRIALS AND NEW TREATMENTS BEFORE THEY BECOME AVAILABLE TO THE GENERAL PUBLIC. THIS ALLOWS PATIENTS TO BE MORE ACTIVE IN THEIR HEALTH CARE.
CLINICAL RESEARCH LIMR CLINICAL RESEARCH IS CONDUCTED PRIMARILY IN ONCOLOGY AND CARDIOLOGY BUT ALSO INCLUDES OTHER DISEASES AND DISORDERS. THIS MEANS PATIENTS AND PARTICIPANTS HAVE ACCESS TO STATE-OF-THE-ART CLINICAL TRIALS AND NEW TREATMENTS BEFORE THEY BECOME AVAILABLE TO THE GENERAL PUBLIC. THIS ALLOWS PATIENTS TO BE MORE ACTIVE IN THEIR HEALTH CARE.
NEW TECHNOLOGY / INNOVATIONS / OTHER LIMR HAS INITIATED A UNIQUE HYBRID MIX OF KNOWLEDGE-BASED ACADEMIC CULTURE WITH INVENTION-BASED ENTREPRENEURIAL CULTURE. IT IS CALLED AN ACAPRENEURIAL STRATEGY. TO DATE, MORE THAN 15 BIOMEDICAL START-UP COMPANIES HAVE INCUBATED IN LIMR SIDE-BY-SIDE WITH OUR RESEARCH LABORATORIES.
NEW TECHNOLOGY / INNOVATIONS / OTHER LIMR HAS INITIATED A UNIQUE HYBRID MIX OF KNOWLEDGE-BASED ACADEMIC CULTURE WITH INVENTION-BASED ENTREPRENEURIAL CULTURE. IT IS CALLED AN ACAPRENEURIAL STRATEGY. TO DATE, MORE THAN 15 BIOMEDICAL START-UP COMPANIES HAVE INCUBATED IN LIMR SIDE-BY-SIDE WITH OUR RESEARCH LABORATORIES.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
John J Lynch III Ex-Officio Trustee | Trustee | 1 | $0 |
Phillip Robinson Ex-Officio Trustee | Trustee | 1 | $0 |
Patrick Ross Jr Ex-Officio Trustee | Trustee | 1 | $0 |
Alexander Uribe Ex-Officio Trustee | Trustee | 1 | $0 |
Joseph Gobern Ex-Officio Trustee | Trustee | 1 | $0 |
George C Prendergast President & Ex-Officio Trustee | OfficerTrustee | 40 | $431,445 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Rmcci Professional Svcs | 6/29/22 | $147,611 |
Rmcci Professional Svcs | 6/29/22 | $147,611 |
American Institute For Voice And Ea Research | 6/29/22 | $191,638 |
American Institute For Voice And Ea Research | 6/29/22 | $191,638 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $965,458 |
| Government grants | $2,764,825 |
| All other contributions, gifts, grants, and similar amounts not included above | $734,406 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $4,464,689 |
| Total Program Service Revenue | $4,168,577 |
| Investment income | -$93,775 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $46,759 |
| Net Rental Income | $342,201 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $11,705,452 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $1,954,701 |
| Compensation of current officers, directors, key employees. | $698,982 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $5,733,951 |
| Pension plan accruals and contributions | $496,877 |
| Other employee benefits | $780,199 |
| Payroll taxes | $510,987 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $323,491 |
| Fees for services: Accounting | $93,900 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $1,738,871 |
| Advertising and promotion | $0 |
| Office expenses | $27,661 |
| Information technology | $11,394 |
| Royalties | $6,243 |
| Occupancy | $2,631,180 |
| Travel | $16,467 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $8 |
| Interest | $80,253 |
| Payments to affiliates | $655,886 |
| Depreciation, depletion, and amortization | $388,092 |
| Insurance | $8,314 |
| All other expenses | $21,663 |
| Total functional expenses | $18,256,170 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $2,668,855 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $1,384,649 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $186,157 |
| Net Land, buildings, and equipment | $1,673,704 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $245,560 |
| Intangible assets | $1,600 |
| Other assets | $14,284,622 |
| Total assets | $20,445,147 |
| Accounts payable and accrued expenses | $5,785,584 |
| Grants payable | $0 |
| Deferred revenue | $1,088,342 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $12,952,110 |
| Total liabilities | $19,826,036 |
| Net assets without donor restrictions | -$734,866 |
| Net assets with donor restrictions | $1,353,977 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $20,445,147 |